Soaanz generic
Soaanz is a drug owned by Sarfe Pharms. It contains the active ingredient torsemide and was first authorized for market use on 14 June, 2021. Soaanz has a total of 1 patent, none of which have expired yet.
When will Soaanz generic be available?
The potential for a Soaanz generic release exists, but not until after 06 October, 2033. This is due to the expiration date of its last patent, US10154963, titled 'Controlled-release formulations comprising Torsemide.'
Soaanz uses
Soaanz, containing torsemide, is commonly used in tablet form. torsemide is effective in treating oedema (water retention) caused by certain medical conditions such as liver disease, kidney disease, and congestive heart failure.
Soaanz patent expiration
Soaanz is protected by 1 patent, with none having expired. The last patent is expected to expire on 06 October, 2033, after which the generic version of Soaanz could be available. Below are the details of the patent: